Evonik Industries AG (XSWX:EVK) Operating Income: CHF530 Mil (TTM As of Mar. 2026)


XSWX:EVK Evonik Industries AG XSWX:EVK
16 GF Score
Price CHF14.54
GF Value CHF14.43
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Evonik Industries AG Operating Income?

Evonik Industries AG XSWX:EVK 16 Operating Income is CHF530 Mil as of Mar. 2026. GuruFocus rates XSWX:EVK with a GF Score™ of 16/100 and a GF Value™ of CHF14.43 (Fairly Valued). The stock has 8 warning signs investors should review.

Evonik Industries AG's Operating Income for the three months ended in Mar. 2026 was CHF208 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was CHF530 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Evonik Industries AG's Operating Income for the three months ended in Mar. 2026 was CHF208 Mil. Evonik Industries AG's Revenue for the three months ended in Mar. 2026 was CHF3,119 Mil. Therefore, Evonik Industries AG's Operating Margin % for the quarter that ended in Mar. 2026 was 6.65%.

Evonik Industries AG's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Evonik Industries AG's annualized ROC % for the quarter that ended in Mar. 2026 was 4.06%. Evonik Industries AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 11.32%.


Evonik Industries AG  (XSWX:EVK) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Evonik Industries AG's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=830.08 * ( 1 - 29.51% )/( (14682.929 + 14161.388)/ 2 )
=585.123392/14422.1585
=4.06 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=16778.757 - 1514.483 - ( 581.345 - max(0, 3105.484 - 4634.897+581.345))
=14682.929

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=16799.071 - 1908.634 - ( 729.049 - max(0, 3275.714 - 4943.152+729.049))
=14161.388

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Evonik Industries AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=851.924/( ( (6436.787 + max(1384.777, 0)) + (6296.58 + max(938.389, 0)) )/ 2 )
=851.924/( ( 7821.564 + 7234.969 )/ 2 )
=851.924/7528.2665
=11.32 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1429.568 + 2146.218 + 376.987) - (1514.483 + 0 + 1053.513)
=1384.777

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1572.78 + 2210.811 + 430.512) - (1908.634 + 0 + 1367.08)
=938.389

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Evonik Industries AG's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=207.52/3119.164
=6.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Evonik Industries AG Operating Income Related Terms


Evonik Industries AG Operating Income Historical Data

* Premium members only.

The historical data trend for Evonik Industries AG's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evonik Industries AG Operating Income Chart

Evonik Industries AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,280.03 1,240.49 -93.36 596.58 598.14

Evonik Industries AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 283.71 219.48 -24.29 126.91 207.52
XSWX:EVK
16GF Score
Evonik Industries AG XSWX:EVK
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evonik Industries AG Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF530 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of CHF530 Mil mean?
Evonik Industries AG (XSWX:EVK) has a Operating Income of CHF530 Mil as of Mar. 2026. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Evonik Industries AG and its competitors.
Is Evonik Industries AG's Operating Income too high?
Evonik Industries AG's current Operating Income is CHF530 Mil. Overall, Evonik Industries AG has a GF Score™ of 16/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Evonik Industries AG's Operating Income compare to LIN and SHW?
Evonik Industries AG's Operating Income of CHF530 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Chemicals company?
A good Operating Income depends on the Chemicals industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Evonik Industries AG and its competitors. Evonik Industries AG's current Operating Income is CHF530 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evonik Industries AG stock overvalued right now?
Based on GuruFocus' analysis, Evonik Industries AG (XSWX:EVK) is currently considered Fairly Valued. The stock's GF Value™ is CHF14.43, compared to a current price of CHF14.54 — trading 0.8% above its estimated fair value. The current Operating Income is CHF530 Mil. Evonik Industries AG's overall GF Score™ is 16/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For Evonik Industries AG (XSWX:EVK), the current Operating Income is CHF530 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evonik Industries AG (XSWX:EVK) Overvalued in 2026?

Based on GuruFocus' analysis, Evonik Industries AG stock appears to be overvalued. The current stock price of CHF14.54 is trading 0.8% above its estimated GF Value™ of CHF14.43. GuruFocus considers Evonik Industries AG to be Fairly Valued.

Key valuation signals for XSWX:EVK:

  • Operating Income: CHF530 Mil
  • GF Value™: CHF14.43 vs. price of CHF14.54 (0.8% above fair value)
  • GF Score™: 16/100 with 8 warning signs

No single metric tells the full story. See the XSWX:EVK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Evonik Industries AG Business Description

Address Rellinghauser Strasse 1-11, Essen, NW, DEU, 45128
Evonik Industries AG is a chemicals company that develops and manufactures specialty chemicals and solutions for a wide range of industries. Its products include high-performance polymers, hydrogen peroxide, silicas, additives for coatings and adhesives, and amino acids for animal nutrition. It operates through three segments: Advanced Technologies, which focuses on technology-driven businesses such as high-performance polymers, silicas, and hydrogen peroxide; Custom Solutions, which develops additives, catalysts, and ingredients for personal care and pharmaceutical applications; and Infrastructure, which provides site-related infrastructure services and includes the Oxeno C4 chemicals business. It generates sales across Europe, Middle East & Africa, the Americas, and Asia-Pacific.
16GF Score

Get the complete analysis for XSWX:EVK

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF14.54
Price
CHF14.43
GF Value